369 related articles for article (PubMed ID: 24282022)
1. Stability of monoclonal antibodies at high-concentration: head-to-head comparison of the IgG1 and IgG4 subclass.
Neergaard MS; Nielsen AD; Parshad H; Van De Weert M
J Pharm Sci; 2014 Jan; 103(1):115-27. PubMed ID: 24282022
[TBL] [Abstract][Full Text] [Related]
2. Viscosity of high concentration protein formulations of monoclonal antibodies of the IgG1 and IgG4 subclass - prediction of viscosity through protein-protein interaction measurements.
Neergaard MS; Kalonia DS; Parshad H; Nielsen AD; Møller EH; van de Weert M
Eur J Pharm Sci; 2013 Jun; 49(3):400-10. PubMed ID: 23624326
[TBL] [Abstract][Full Text] [Related]
3. Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life.
Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Volkin DB; Weis DD
MAbs; 2015; 7(1):84-95. PubMed ID: 25524268
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody.
Arora J; Hickey JM; Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Weis DD; Volkin DB
MAbs; 2015; 7(3):525-39. PubMed ID: 25875351
[TBL] [Abstract][Full Text] [Related]
5. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.
Bhambhani A; Kissmann JM; Joshi SB; Volkin DB; Kashi RS; Middaugh CR
J Pharm Sci; 2012 Mar; 101(3):1120-35. PubMed ID: 22147527
[TBL] [Abstract][Full Text] [Related]
6. Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates.
Brummitt RK; Nesta DP; Chang L; Chase SF; Laue TM; Roberts CJ
J Pharm Sci; 2011 Jun; 100(6):2087-103. PubMed ID: 21213308
[TBL] [Abstract][Full Text] [Related]
7. Influence of pH on heat-induced aggregation and degradation of therapeutic monoclonal antibodies.
Ishikawa T; Ito T; Endo R; Nakagawa K; Sawa E; Wakamatsu K
Biol Pharm Bull; 2010; 33(8):1413-7. PubMed ID: 20686240
[TBL] [Abstract][Full Text] [Related]
8. Effects of subclass change on the structural stability of chimeric, humanized, and human antibodies under thermal stress.
Ito T; Tsumoto K
Protein Sci; 2013 Nov; 22(11):1542-51. PubMed ID: 23963869
[TBL] [Abstract][Full Text] [Related]
9. Understanding the Increased Aggregation Propensity of a Light-Exposed IgG1 Monoclonal Antibody Using Hydrogen Exchange Mass Spectrometry, Biophysical Characterization, and Structural Analysis.
Bommana R; Chai Q; Schöneich C; Weiss WF; Majumdar R
J Pharm Sci; 2018 Jun; 107(6):1498-1511. PubMed ID: 29408480
[TBL] [Abstract][Full Text] [Related]
10. Differences in human IgG1 and IgG4 S228P monoclonal antibodies viscosity and self-interactions: Experimental assessment and computational predictions of domain interactions.
Lai PK; Ghag G; Yu Y; Juan V; Fayadat-Dilman L; Trout BL
MAbs; 2021; 13(1):1991256. PubMed ID: 34747330
[TBL] [Abstract][Full Text] [Related]
11. Investigating the Degradation Behaviors of a Therapeutic Monoclonal Antibody Associated with pH and Buffer Species.
Zheng S; Qiu D; Adams M; Li J; Mantri RV; Gandhi R
AAPS PharmSciTech; 2017 Jan; 18(1):42-48. PubMed ID: 26340951
[TBL] [Abstract][Full Text] [Related]
12. Molecular Insights into the Thermal Stability of mAbs with Variable-Temperature Ion-Mobility Mass Spectrometry.
Pacholarz KJ; Peters SJ; Garlish RA; Henry AJ; Taylor RJ; Humphreys DP; Barran PE
Chembiochem; 2016 Jan; 17(1):46-51. PubMed ID: 26534882
[TBL] [Abstract][Full Text] [Related]
13. Nonnative aggregation of an IgG1 antibody in acidic conditions, part 2: nucleation and growth kinetics with competing growth mechanisms.
Brummitt RK; Nesta DP; Chang L; Kroetsch AM; Roberts CJ
J Pharm Sci; 2011 Jun; 100(6):2104-19. PubMed ID: 21213307
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of pH and ionic strength on protein-protein interactions, unfolding, and aggregation for IgG1 antibodies.
Sahin E; Grillo AO; Perkins MD; Roberts CJ
J Pharm Sci; 2010 Dec; 99(12):4830-48. PubMed ID: 20821389
[TBL] [Abstract][Full Text] [Related]
15. Effect of ionic strength and pH on the physical and chemical stability of a monoclonal antibody antigen-binding fragment.
Wang T; Kumru OS; Yi L; Wang YJ; Zhang J; Kim JH; Joshi SB; Middaugh CR; Volkin DB
J Pharm Sci; 2013 Aug; 102(8):2520-37. PubMed ID: 23824562
[TBL] [Abstract][Full Text] [Related]
16. High Throughput Prediction Approach for Monoclonal Antibody Aggregation at High Concentration.
Zidar M; Šušterič A; Ravnik M; Kuzman D
Pharm Res; 2017 Sep; 34(9):1831-1839. PubMed ID: 28593474
[TBL] [Abstract][Full Text] [Related]
17. Mapping the mAb Aggregation Propensity Using Self-Interaction Chromatography as a Screening Tool.
Hedberg SHM; Lee D; Mishra Y; Haigh JM; Williams DR
Anal Chem; 2018 Mar; 90(6):3878-3885. PubMed ID: 29446917
[TBL] [Abstract][Full Text] [Related]
18. Acid-induced aggregation of human monoclonal IgG1 and IgG2: molecular mechanism and the effect of solution composition.
Hari SB; Lau H; Razinkov VI; Chen S; Latypov RF
Biochemistry; 2010 Nov; 49(43):9328-38. PubMed ID: 20843079
[TBL] [Abstract][Full Text] [Related]
19. Excipients differentially influence the conformational stability and pretransition dynamics of two IgG1 monoclonal antibodies.
Thakkar SV; Joshi SB; Jones ME; Sathish HA; Bishop SM; Volkin DB; Middaugh CR
J Pharm Sci; 2012 Sep; 101(9):3062-77. PubMed ID: 22581714
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal Antibodies Follow Distinct Aggregation Pathways During Production-Relevant Acidic Incubation and Neutralization.
Skamris T; Tian X; Thorolfsson M; Karkov HS; Rasmussen HB; Langkilde AE; Vestergaard B
Pharm Res; 2016 Mar; 33(3):716-28. PubMed ID: 26563206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
